Ticker Details
Foghorn Therapeutics Inc.
IPO Date:	October 23, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$335.67M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.35 | 4.02%
Avg Daily Range (30 D):	$0.18 | 3.22%
Avg Daily Range (90 D):	$0.16 | 3.23%

Institutional Daily Volume
Avg Daily Volume:	.12M
Avg Daily Volume (30 D):	.15M
Avg Daily Volume (90 D):	.17M

Trade Size
Avg Trade Size (Sh.):	88
Avg Trade Size (Sh.) (30 D):	70
Avg Trade Size (Sh.) (90 D):	80

Institutional Trades
Total Institutional Trades:	84
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$.86M
Avg Institutional Trade (90 D):	$.7M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.61M
Avg Closing Trade (30 D):	$.59M
Avg Closing Trade (90 D):	$.59M
Avg Closing Volume:	219.86K

News

Jan 14, 2026 @ 3:52 PM Precision Killers: Why Big Pharma is Betting Billi... Source: Prnewswire

Jan 10, 2026 @ 3:20 AM Foghorn Therapeutics Highlights January Equity Fin... Source: Na

Nov 17, 2025 @ 11:00 AM 4DMT Appoints Kristian Humer as Chief Financial Of... Source: 4D Molecular Therapeutics

Aug 27, 2025 @ 11:00 AM Foghorn Therapeutics to Participate in Three Upcom... Source: Karin Hellsvik

Aug 5, 2025 @ 11:00 AM Foghorn Therapeutics Provides Second Quarter 2025 ... Source: Foghorn Therapeutics Inc.

Financials
	TTM	Q3 2025	Q2 2025
Basic EPS	$-1.13	$-.25	$-.28
Diluted EPS	$-1.13	$-.25	$-.28
Revenue	$24.52M	$8.15M	$7.56M
Gross Profit
Net Income / Loss	$-72.12M	$-15.85M	$-17.94M
Operating Income / Loss	$-86.52M	$-18.5M	$-21.1M
Cost of Revenue
Net Cash Flow	$33.2M	$16.76M	$13.09M
PE Ratio